my account  log out
 

Mifepristone

Create: 12/05/2017
Expired Date:never
Category: Specialty [Chemical]
Message:Mifepristone Molecular Formula:C29H35NO2 CAS Registry Number:84371-65-3 Synonyms:Estra-4,9-dien-3-one,11-[4-(dimethylamino)- phenyl]-17-hydroxy-17-(1-propynyl)-,(11a,- 17a)-; Mifepristone [USAN:BAN:INN]; 17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one; Mifeprex; Mifepristonum [Latin]; R 38486; RU 38486; 11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on; Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-; Prestwick_570; Mifegyne; (11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one; RU-486; RU486; 11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on; RU 486-6; 17-(1-propynyl)estra-4,9-dien-3-one; Chemical Properties Appearance:Pale Yellow Solid Molecular Weight:429.5937 Density:1.18 g/cm3 Boiling Point:628.6 °C at 760 mmHg Melting Point:195-198°C Flash Point:334 °C Storage Temperature:2-8°C Refractive index:1.623 Solubility:Soluble to 100 mM in DMSO and to 50 mM in Ethanol Biological Activity:Selective antagonist at progesterone (PR) and glucocorticoid (GR) receptors in vitro and in vivo . Is a silent antagonist at PR and has a higher affinity than progesterone. Has higher affinity for GR than dexamethasone. Stability:Stable at normal temperatures and pressures. Usage:A progesterone receptor antagonist with partial agonist activity. Abortifacient.
City:Wuhan Hubei[CN] 
Location:
 
Jun 20 2018 L-Lysine L-aspartate 27348-32-9522
Jun 20 2018 L-Proline147-85-3531
Jun 20 2018 L-Cystine 56-89-3515
Jun 20 2018 L-arginine L- glutamic acid 4320-30-3509
Jun 20 2018 L-Se-methylselenocysteine 26046 -90-2550
Jun 20 2018 L-Asparagine 70-47-3525
Jun 20 2018 L-Aspartate Calcium 21059-46-1518
Jun 20 2018 sodium aspartate 5598-53-8515
Jun 20 2018 DL-Aspartic Acid 617-45-8510
Jun 20 2018 D (-)-Glutamine 5959-95-5527

return back

Copyright © toextrade Inc. All rights reserved. Contact us